Cargando…
Antiviral Agents Against Ebola Virus Infection: Repositioning Old Drugs and Finding Novel Small Molecules
Ebola virus (EBOV) causes a deadly hemorrhagic syndrome in humans with mortality rate up to 90%. First reported in Zaire in 1976, EBOV outbreaks showed a fluctuating trend during time and fora long period it was considered a tragic disease confined to the isolated regions of the African continent wh...
Autores principales: | Fanunza, Elisa, Frau, Aldo, Corona, Angela, Tramontano, Enzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112331/ https://www.ncbi.nlm.nih.gov/pubmed/32287476 http://dx.doi.org/10.1016/bs.armc.2018.08.004 |
Ejemplares similares
-
Development and Validation of a Novel Dual Luciferase Reporter Gene Assay to Quantify Ebola Virus VP24 Inhibition of IFN Signaling
por: Fanunza, Elisa, et al.
Publicado: (2018) -
Relevance of Ebola virus VP35 homo-dimerization on the type I
interferon cascade inhibition
por: Di Palma, Francesco, et al.
Publicado: (2019) -
The Methanolic Extract of Perilla frutescens Robustly Restricts Ebola Virus Glycoprotein-Mediated Entry
por: Kuo, Yu-Ting, et al.
Publicado: (2021) -
Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity
por: Flego, Michela, et al.
Publicado: (2019) -
Editorial: Viruses, innate immunity, and antiviral strategies: from basic research to clinical applications
por: Fanunza, Elisa, et al.
Publicado: (2023)